AngioDynamics Direct Expenses from 2010 to 2023

ANGO Stock  USD 12.45  0.20  1.63%   
AngioDynamics Direct Expenses yearly trend continues to be very stable with very little volatility. Direct Expenses is likely to drop to about 130.8 M. During the period from 2010 to 2023, AngioDynamics Direct Expenses quarterly data regression pattern had range of 91,019,000 and median of  150,487,000. AngioDynamics Interest Expense is very stable at the moment as compared to the past year. AngioDynamics reported last year Interest Expense of 619,200. As of 22nd of March 2023, Operating Expenses is likely to grow to about 224.5 M, while Direct Expenses is likely to drop about 130.8 M.
  
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics main balance sheet or income statement drivers, such as Direct Expenses of 130.8 M, Cost of Revenue of 131.1 M or Gross Profit of 145.1 M, as well as many exotic indicators such as Interest Coverage of 2.76, Long Term Debt to Equity of 0.0695 or PPandE Turnover of 6.82. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules. It can also supplement AngioDynamics' financial leverage analysis and stock options assessment as well as various AngioDynamics Technical models . Please continue to the analysis of AngioDynamics Correlation against competitors.

AngioDynamics Direct Expenses Breakdown

Showing smoothed Direct Expenses of AngioDynamics with missing and latest data points interpolated. AngioDynamics' Direct Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Direct Expenses10 Years Trend
Down
Very volatile
   Direct Expenses   
       Timeline  

AngioDynamics Direct Expenses Regression Statistics

Arithmetic Mean143,749,667
Geometric Mean140,176,044
Coefficient Of Variation22.21
Mean Deviation27,487,618
Median150,487,000
Standard Deviation31,933,102
Range91,019,000
R-Value(0.011434)
R-Squared0.00013074
Significance0.97
Slope(87,282)

AngioDynamics Direct Expenses History

2023130.8 M
2022135.4 M
2021150.5 M
2020134.2 M
2019113.9 M
2018114.6 M
2017167.4 M
2016173.5 M
2015179.6 M
2014180.1 M
2013174.6 M

About AngioDynamics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AngioDynamics income statement, its balance sheet, and the statement of cash flows. AngioDynamics investors use historical funamental indicators, such as AngioDynamics's Direct Expenses, to determine how well the company is positioned to perform in the future. Although AngioDynamics investors may use each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AngioDynamics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AngioDynamics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Direct Expenses135.4 M130.8 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in AngioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Probability Of Bankruptcy Now

   

Probability Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics

+0.74ABTAbbott Laboratories Fiscal Quarter End 31st of March 2023 PairCorr
+0.65ACHCAcadia Healthcare Fiscal Quarter End 31st of March 2023 PairCorr

Moving against AngioDynamics

-0.53ATECAlphatec Holdings Fiscal Quarter End 31st of March 2023 PairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of AngioDynamics Correlation against competitors. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Bond Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.84) 
Revenue Per Share
8.353
Quarterly Revenue Growth
0.091
Return On Assets
(0.0247) 
Return On Equity
(0.08) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.